592
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Targeting human DNA polymerase α for the inhibition of keratinocyte proliferation. Part 1. Homology model, active site architecture and ligand binding

, , , &
Pages 94-100 | Received 24 Jan 2007, Accepted 29 Mar 2007, Published online: 04 Oct 2008
 

Abstract

In order to understand the binding modes of human DNA polymerase α (pol α) inhibitors on a molecular level, a 3D homology model of the active site of the enzyme was proposed based on the application of molecular modelling methods and molecular dynamic simulations using available crystal coordinates of pol α relatives. Docking results for a series of known nucleotide analogue inhibitors were consistent with reported experimental binding data and offered the possibility to elucidate structure-activity relationships via investigations of active site-inhibitor interactions. Furthermore, the study could explain, at least partially, the inhibitory effect of aphidicolin on pol α. In molecular dynamics simulations, aphidicolin occupied the catalytic centre, but acted in a not truly competitive manner with respect to nucleotides. It destabilized the replicating “closed” form of the pol α and transferred the enzyme into the inactive “open” conformation. This result is consistent with recent experiments on the binding mode of aphidicolin.

Acknowledgements

This work was financially supported by RIEMSER Arzneimittel AG, Greifswald - Insel Riems, Germany.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.